Acute Myeloid Leukemia- A Retrospective Claims Analysis of Resource Utilization and Expenditures for De Novo Patients from First-Line Induction to Remission and Relapse

Full Text

CEB1- PHARMACOGENOMICS- EVALUATING THE ECONOMIC IMPACT

DL Veenstra MK Higashi

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now